GSK Gross Profit 2010-2023 | GSK
GSK annual/quarterly gross profit history and growth rate from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- GSK gross profit for the quarter ending March 31, 2023 was $6.084B, a 25.55% decline year-over-year.
- GSK gross profit for the twelve months ending March 31, 2023 was $22.366B, a 30.79% decline year-over-year.
- GSK annual gross profit for 2022 was $24.454B, a 21% decline from 2021.
- GSK annual gross profit for 2021 was $30.955B, a 7.65% increase from 2020.
- GSK annual gross profit for 2020 was $28.755B, a 2.87% increase from 2019.
GSK Annual Gross Profit
(Millions of US $) |
| 2022 |
$24,454 |
| 2021 |
$30,955 |
| 2020 |
$28,755 |
| 2019 |
$27,953 |
| 2018 |
$27,470 |
| 2017 |
$25,575 |
| 2016 |
$25,207 |
| 2015 |
$23,042 |
| 2014 |
$25,847 |
| 2013 |
$28,041 |
| 2012 |
$29,383 |
| 2011 |
$32,176 |
| 2010 |
$32,163 |
| 2009 |
$32,865 |
GSK Quarterly Gross Profit
(Millions of US $) |
| 2023-03-31 |
$6,084 |
| 2022-12-31 |
$3,947 |
| 2022-09-30 |
$6,367 |
| 2022-06-30 |
$5,967 |
| 2022-03-31 |
$8,172 |
| 2021-12-31 |
$7,872 |
| 2021-09-30 |
$8,533 |
| 2021-06-30 |
$7,741 |
| 2021-03-31 |
$6,810 |
| 2020-12-31 |
$7,345 |
| 2020-09-30 |
$7,442 |
| 2020-06-30 |
$6,422 |
| 2020-03-31 |
$7,546 |
| 2019-12-31 |
$7,313 |
| 2019-09-30 |
$7,571 |
| 2019-06-30 |
$6,650 |
| 2019-03-31 |
$6,419 |
| 2018-12-31 |
$4,201 |
| 2018-09-30 |
$7,109 |
| 2018-06-30 |
$6,805 |
| 2018-03-31 |
$9,355 |
| 2017-12-31 |
$6,734 |
| 2017-09-30 |
$6,796 |
| 2017-06-30 |
$6,012 |
| 2017-03-31 |
$6,034 |
| 2016-12-31 |
$6,311 |
| 2016-09-30 |
$6,589 |
| 2016-06-30 |
$6,325 |
| 2016-03-31 |
$5,869 |
| 2015-12-31 |
$5,757 |
| 2015-09-30 |
$6,081 |
| 2015-06-30 |
$5,949 |
| 2015-03-31 |
$5,324 |
| 2014-12-31 |
$6,090 |
| 2014-09-30 |
$6,063 |
| 2014-06-30 |
$6,574 |
| 2014-03-31 |
$6,555 |
| 2013-12-31 |
$7,173 |
| 2013-09-30 |
$7,246 |
| 2013-06-30 |
$7,137 |
| 2013-03-31 |
$6,804 |
| 2012-12-31 |
$7,555 |
| 2012-09-30 |
$7,224 |
| 2012-06-30 |
$7,055 |
| 2012-03-31 |
$7,874 |
| 2011-12-31 |
$8,004 |
| 2011-09-30 |
$8,083 |
| 2011-06-30 |
$8,267 |
| 2011-03-31 |
$7,670 |
| 2010-12-31 |
$8,371 |
| 2010-09-30 |
$7,606 |
| 2010-06-30 |
$6,724 |
| 2010-03-31 |
$8,238 |
| 2009-12-31 |
$9,776 |
| 2009-09-30 |
$8,171 |
| 2009-06-30 |
$7,907 |
| 2009-03-31 |
$7,164 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$69.839B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
